I'm adding a new stock to my watchlist. $BCDA has Market Cap of 36.28 M and an Enterprise Value of 31.32 M. It has 31.3% insider ownership with the management buying shares each month since September 2022 through December 2022. They create cellular therapeutics for cardiovascular diseases. Their revenue has been growing 11% per year over the past 5 years. Price...
BCDA has an upcoming CardiAMP Heart Failure DSMB review on the 30th of this month (August). Although the treatment indicated no significant safety concerns, I have reasonable doubt that this won't go through to be accepted by the FDA; the Phase III to NDA/BLA is about a 58.1% chance, the NDA/BLA to Approval is a 85.3% chance, and then the Phase I to Approval is a...
Pupm&Dump trading strategy idea.
$BCDA is rising without clear preconditions today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $5,04;
stop-loss — $5,49;
take-profit — $4,14;
Do not view this idea as a recommendation for trading or...
1. BioCardia Anticipates DSMB Feedback on Interim Data From Pivotal Phase 3 CardiAMP Heart Failure Trial
BCDA today announces that it anticipates data safety monitoring board (DSMB) verbal feedback by the end of December 15, 2020 on interim data from the Company’s pivotal Phase 3 CardiAMP Heart Failure Trial that is currently enrolling nationwide for infusion...
Trade Safe! Don`t be greedy!
Take care and place small trades! If necessary, I will place more long trades at this asset!
In my opinion, this stock is at a good opportunity and has good potential for the stock price to go up!
This is an emergency buy signal!
13 Million Market Cap!
Stock dropped 26 Percent Today Due to Stock offering. It wasn’t a bad thing, however investors were afraid and sold. Therefore this is a great entry as price is expected to bounce back for profits.
Target could be 10 bucks
